Clinical and Economic Correlates of Pharmacotherapy in Patients with Essential Tremor
Rajesh Pahwa, Kalea Colletta, Donald Higgins, Bridgette Kanz Schroader, Brian M Davis, Liana Hennum, Elan D Louis · 2024
Read Clinical and Economic Correlates of Pharmacotherapy in Patients with Essential Tremor by Rajesh Pahwa, Kalea Colletta, Donald Higgins, Bridgette Kanz Schroader, Brian M Davis, Liana Hennum, Elan D Louis (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11661014.txt.
Description
Rajesh Pahwa and co-authors study in 2024 how drug treatment for essential tremor tracks with health costs and other illnesses. Essential tremor is among the most common movement disorders, yet drug options are few, often weak, and laden with side effects. Many patients quit their pills or stack several together.
Using a large insurance claims bank, the team sorted tens of thousands of tremor patients by how many tremor drugs they took. Groups ran from none to three or more, compared with millions without tremor over two years. Tremor patients in both insurance groups filled more distinct drugs. They also carried more extra conditions, such as anxiety, depression, and falls, and used more care at higher cost. Each of those gaps widened step by step as the drug count rose. The authors link heavier drug loads to a heavier overall burden.
Catalog record
| CREATOR | Rajesh Pahwa, Kalea Colletta, Donald Higgins, Bridgette Kanz Schroader, Brian M Davis, Liana Hennum, Elan D Louis |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |